Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Albert Luderer; Leroy Hood; and More

Premium

BioNano Genomics said this week that it has elected Albert Luderer to its board of directors.

Luderer currently serves as CEO and director of Integrated Diagnostics. He was previously president and CEO of BioTrove, now part of Life Technologies. Previously, he served as CEO of Light Sciences and president and COO of BioMérieux.


The Personalized Medicine Coalition has awarded Leroy Hood its 2011 Leadership in Personalized Medicine Award for his "pioneering vision to transform medicine from reactive to predictive, preventive, personalized and participatory (P4 medicine)."

Hood is the president and co-founder of the Institute of Systems Biology, as well as a founder of more than a dozen biotechnology firms including Applied Biosystems, Amgen, and Integrated Diagnostics.


BG Medicine has signed a consulting agreement with Stéphane Bancel, who became chairman of its board of directors in July, that will pay him a fee of $150,000 per year and a consulting bonus up to $50,000 per year.

Bancel formerly was CEO of BioMérieux and an executive at Eli Lilly Laboratories.

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.